Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 3,14,15 Triacetyl Aconitine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112250632B details a green synthesis route for 3,14,15-triacetyl aconitine using DMAP catalysis, offering significant cost reduction and scalable purification for cardiac drug manufacturing.